These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7407335)

  • 21. Disopyramide kinetics in patients with acute myocardial infarction.
    Ilett KF; Madsen BW; Woods JD
    Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption.
    Pao LH; Zhou SY; Cook C; Kararli T; Kirchhoff C; Truelove J; Karim A; Fleisher D
    Pharm Res; 1998 Feb; 15(2):221-7. PubMed ID: 9523307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disopyramide plasma and myocardial tissue concentrations as they relate to antiarrhythmic activity.
    Patterson E; Stetson P; Lucchesi BR
    J Cardiovasc Pharmacol; 1979; 1(5):541-50. PubMed ID: 94410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tablets.
    Graffner C; Lagerström PO; Lundborg PN; Rönn OF
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):414-9. PubMed ID: 7298249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
    Jou MJ; Huang SC; Kiang FM; Lai MY; Chao PD
    J Pharm Pharmacol; 1997 Nov; 49(11):1072-5. PubMed ID: 9401940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics of Norpace.
    Karim A
    Angiology; 1975 Jan; 26(1 Pt 2):85-98. PubMed ID: 1090217
    [No Abstract]   [Full Text] [Related]  

  • 29. Disopyramide pharmacokinetics in patients with acute myocardial infarction.
    Pentikäinen PJ; Huikuri H; Jounela AJ; Wilen G
    Eur J Clin Pharmacol; 1985; 28(1):45-51. PubMed ID: 3987785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
    Jounela AJ; Pentikäinen PJ; Oksanen K
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.
    Hinderling PH; Garrett ER
    J Pharmacokinet Biopharm; 1976 Jun; 4(3):199-230. PubMed ID: 978389
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
    Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of the disopyramide concentration-effect relationship.
    Whiting B; Holford NH; Sheiner LB
    Br J Clin Pharmacol; 1980 Jan; 9(1):67-75. PubMed ID: 7356895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of magnesium bioavailability using stable isotopes and the inductively-coupled plasma mass spectrometry technique in the rat: single and double labelling approaches.
    Coudray C; Pepin D; Tressol JC; Bellanger J; Rayssiguier Y
    Br J Nutr; 1997 Jun; 77(6):957-70. PubMed ID: 9227192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method.
    Strong JM; Dutcher JS; Lee WK; Atkinson AJ
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):613-22. PubMed ID: 1183141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 13C- and 15N-incorporation of doubly stable isotope labelled Lactobacillus johnsonii in humans.
    Wutzke KD; Oetjens I
    Eur J Clin Nutr; 2005 Oct; 59(10):1167-72. PubMed ID: 16034363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stereoselective disposition of disopyramide in the dog.
    Giacomini KM; Giacomini JC; Swezey SE; Harrison DC; Nelson WL; Burke TR; Blaschke TF
    J Cardiovasc Pharmacol; 1980; 2(6):825-32. PubMed ID: 6160331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.